相关实验视频

Updated: Jun 16, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

系统性乳腺细胞瘤:当前状况和2024年的挑战

Celalettin Ustun¹, Fatma Keklik Karadag², Michael A Linden³

¹Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Rush University Medical Center, Chicago, IL.

|January 24, 2025

概括

系统性乳腺细胞瘤 (SM) 管理已经推进了新的分类和KIT抑制剂,改善了晚期疾病的生存率. 然而,对于SM等与相关的血液瘤相关的子集的最佳治疗需要进一步的研究.

科学领域:

血液学血液学血液学
在瘤学瘤学.
罕见疾病罕见疾病

背景情况:

系统性乳腺细胞瘤 (SM) 是一种罕见的克隆性乳腺细胞疾病.
近几十年来,SM生物学,预后和管理方面取得了重大进展.
当前的诊断和预后标准依赖于世卫组织和国际共识分类.

研究的目的:

为了提供系统性乳腺细胞瘤的最新概述.
涵盖最新的诊断方法和患者分类.
根据非先进和先进的SM的临床试验,审查当前的管理策略.

主要方法:

审查最近的文献和临床试验.
综合诊断标准,包括临床,形态,免疫类型和分子数据.
将SM分为非高级 (非AdvSM) 和高级 (AdvSM) 的类别.

主要成果:

新的分类 (WHO,ICC) 有助于MS的诊断和预后.
像阿瓦普利提尼布这样的KIT抑制剂在延长AdvSM.的存活时间方面显示出希望.
有效的治疗方法存在于indolent和AdvSM,但仍然存在挑战.

结论:

诊断SM需要综合的临床和实验室发现.
在KIT抑制剂的进步为AdvSM提供了更好的结果.
需要对SM-AHN等复杂子集进行进一步的前性研究,以确定最佳治疗方法.

更多相关视频

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

相关概念视频

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...